BCRX — BioCryst Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for BioCryst Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	136	300	508	424	389
Net Total Accounts Receivable
Net Total Receivables	22.1	8.65	29.4	50.6	57
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	164	324	566	517	496
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.9	10.9	15.2	15.4	20.9
Long Term Investments
Other Long Term Assets
Total Assets	175	335	588	550	517
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	92.3	106	104	106	150
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	137	354	695	845	972
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.3	-19.3	-107	-295	-456
Total Liabilities & Shareholders' Equity	175	335	588	550	517
Total Common Shares Outstanding